menu search

Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast

Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor Webcast
Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESMO Data Presentation on October 22 at 12:30 p.m. Eastern REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the […] The post Revolution Medicines to Present New Clinical Data at Major Oncology Confe... Read More
Posted: Oct 4 2023, 20:05
Author Name: forextv
Views: 111197

Search within

Pages Search Results: